Related Experiment Video
Updated: Sep 9, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Endothelial Dysfunction in Children with Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Rajesh Verma1, Bobbity Deepthi2, Abhijeet Saha1
1Division of Pediatric Nephrology, Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India.
Insights
Children with frequently relapsing or steroid-dependent nephrotic syndrome experience endothelial dysfunction during relapses. Biomarker levels decreased with treatment, indicating disease activity influences vascular health.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Health in Children
- Endothelial Function Research
Background:
- Frequently relapsing (FR) and steroid-dependent (SD) nephrotic syndrome (NS) in children are linked to endothelial dysfunction and injury.
- This dysfunction increases the risk of accelerated atherosclerosis and adverse cardiovascular events in affected children.
- Understanding these vascular changes is crucial for managing long-term health outcomes.
Purpose of the Study:
- To investigate plasma levels of endothelial dysfunction markers, soluble E-selectin (sE-selectin) and vascular cell adhesion molecule-1 (VCAM-1), in children with FRNS and SDNS during relapse.
- To compare these marker levels in children with FRNS/SDNS during relapse and remission against healthy controls.
Main Methods:
- Fifty-six children (aged 1-16 years) diagnosed with FRNS or SDNS were enrolled at the time of relapse.
- Plasma samples were collected during relapse and followed up to six weeks post-steroid-induced remission.
- Levels of sE-selectin and VCAM-1 were measured and compared between patients and an equal number of controls.
Main Results:
- Plasma sE-selectin and VCAM-1 levels were significantly elevated in children with FRNS/SDNS during relapse (p < 0.0001).
- These marker levels decreased significantly after six weeks of steroid-induced remission, becoming comparable to control levels.
- Elevated serum total cholesterol and triglycerides were observed during relapse and persisted even after remission compared to controls (p < 0.0001).
Conclusions:
- Endothelial dysfunction is confirmed in children with FRNS and SDNS during relapse.
- The degree of endothelial dysfunction appears to be largely dependent on the activity of the nephrotic syndrome.
- These findings highlight the importance of monitoring cardiovascular risk factors in children with FRNS/SDNS.
Background:
Children with frequently relapsing (FR) or steroid-dependent (SD) nephrotic syndrome (NS) show endothelial dysfunction and risk of endothelial injury during relapses, increasing the risk of accelerated atherosclerosis and adverse cardiovascular events. This study examines the plasma levels of markers of endothelial dysfunction [sE-selectin and vascular cell adhesion molecule-1 (VCAM-1)] in children aged 1-16 years with FRNS and SDNS in relapse.
Materials And Methods:
Fifty-six children with FRNS and SDNS between 1 and 16 years were enrolled at the time of relapse and followed till six weeks of steroid-induced remission. Markers of endothelial dysfunction (sE-selectin and VCAM-1) in plasma were measured in these children and in an equal number of controls.
Results:
Plasma sE-selectin and VCAM-1 levels were significantly raised during relapse, declined after six weeks of steroid-induced remission, and became comparable to controls (p < 0.0001). We found high serum total cholesterol and triglycerides levels during relapse that remained elevated even after steroid-induced remission as compared to controls (p < 0.0001). Raised levels of these markers confirm endothelial dysfunction in FRNS and SDNS patients.
Conclusion:
Children with FRNS and SDNS had endothelial dysfunction during relapse, which was largely dependent upon disease activity.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Nephrons

